Probability-based current dipole localization from biomagneticfields

Focal biomagnetic sources are described as pointlike current dipoles. The dipole parameters, position, and moment coordinates are commonly determined from biomagnetic data using iterative nonlinear optimization algorithms such as the Levenberg-Marquardt algorithm. However, even for single-dipole sources, mislocalizations can occur due to side minima of the cost function or due to a wrong choice of the start vector. This can be shown by introducing a cost function where the independent variables are only the position coordinates instead of position and moment coordinates. This dimensional reduction-which is also possible for multiple dipole sources-is achieved by calculating the cost function at each position with the position and data-dependent, optimum dipole moments. The authors call these dipoles with-in a least squares sense-optimum moments, locally optimal dipoles. The visualization of such a single-dipole cost function and of the iteration steps of the Levenberg-Marquardt algorithm show why mislocalizations cannot be avoided. Therefore, the authors propose an alternative noniterative localization algorithm for single-dipole sources without this drawback. It uses localization probabilities calculated by means of the locally optimal dipoles. Besides the determination of the dipole parameters, the proposed algorithm furnishes a reliable error for each localization. Its effectiveness is shown with simulated and real patient data     

Mine operating accurate stability control with optical fibersensing and Bragg grating technology: the European BRITE/EURAM STABILOSproject

Recent developments of stability control in mines, essentially based on Ge-doped fiber Bragg gratings (FBG) are reported including results about the different aspects of the system: accurate characterizations of FBG, sensor network topology and multiplexing method, user interface design and sensor packaging     

The Electrochemistry of Liposomes

This review aims to summarize the current state of research concerning the interaction of electrodes with liposomes suspended in solutions. Main attention is given to the complex mechanism of adhesion and spreading of liposomes on mercury electrodes. That mechanism can be studied with the help of chronoamperometry, where each adhesion-spreading event appears as a capacitive current spike. Integration of these spikes produces charge versus time transients that can be modeled and simulated, revealing the details of the multi-step adhesion-spreading process. Whereas the number of spikes per time mirrors the macro-kinetics, the analysis of the time behavior of each spike mirrors the micro-kinetics of each adhesion-spreading event. The reviewed studies show that this approach provides a new tool to study the properties of liposome membranes. The adhesion-spreading of liposomes on mercury electrodes has strong similarities to the process of vesicle fusion, which makes these studies a biomimetic model allowing one to deduce the effects of foreign molecules in bilayer membranes.     

Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients

The liposomal formulation of amphotericin B (AmBisome) greatly reduces the acute and chronic side effects of the parent drug. The present study describes the pharmacokinetic characteristics of AmBisome applied to 10 patients at a dose of 2.8 to 3.0 mg/kg of body weight and compares them to the pharmacokinetics observed in 6 patients treated with amphotericin B deoxycholate at the standard dose of 1.0 mg/kg. Interpatient variabilities of amphotericin B peak concentrations (Cmax) and areas under concentration-time curves (AUC) were 8- to 10-fold greater for patients treated with AmBisome than for patients treated with amphotericin B deoxycholate. At the threefold greater dose of AmBisome, median Cmaxs were 8.4-fold higher (14.4 versus 1.7 microg/ml) and median AUCs exceeded those observed with amphotericin B deoxycholate by 9-fold. This was in part explained by a 5.7-fold lower volume of distribution (0.42 liters/kg) in AmBisome-treated patients. The elimination of amphotericin B from serum was biphasic for both formulations. However, the apparent half-life of elimination was twofold shorter for AmBisome (P = 0.03). Neither hemodialysis nor hemofiltration had a significant impact on AmBisome pharmacokinetics as analyzed in one patient. In conclusion, the liposomal formulation of amphotericin B significantly (P = 0.001) reduces the volume of drug distribution, thereby allowing for greater drug concentrations in serum. The low toxicity of AmBisome therefore cannot readily be explained by its serum pharmacokinetics.